Vanguard Group
VAXX

Vanguard Group’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Vanguard Group’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,411,679
Closed -$1.73M – 4486
2024
Q1 		$1.73M Buy
2,411,679
+20,843
+0.9% +$15.1K ﹤0.01% 3634
2023
Q4 		$2.03M Buy
2,390,836
+13,451
+0.6% +$13K ﹤0.01% 3595
2023
Q3 		$3.26M Sell
2,377,385
-6,810
-0.3% -$14.8K ﹤0.01% 3422
2023
Q2 		$6.01M Buy
2,384,195
+225,253
+10% +$477K ﹤0.01% 3219
2023
Q1 		$4.9M Buy
2,158,942
+15,625
+0.7% +$39.6K ﹤0.01% 3312
2022
Q4 		$3M Sell
2,143,317
-68,869
-3% -$116K ﹤0.01% 3516
2022
Q3 		$4.38M Buy
2,212,186
+681,666
+45% +$1.42M ﹤0.01% 3396
2022
Q2 		$2.4M Buy
1,530,520
+1,475,399
+2,677% +$5.58M ﹤0.01% 3730
2022
Q1 		$237K Sell
55,121
-4,879
-8% -$26.9K ﹤0.01% 4513
2021
Q4 		$337K Buy
+60,000
New +$620K ﹤0.01% 4492

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Vanguard Group's VAXX Position: Q2 2024 in Review

Vanguard Group sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 2,411,679 shares — an estimated $1.73M sold.

Vanguard Group first reported a position in VAXX in Q4 2021 and held it in 10 quarters. The position peaked at $6.01M in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Vanguard Group reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Vanguard Group sold 2,411,679 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $1.73M.
  • Vanguard Group first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2021 and held it in 10 quarters.
  • Vanguard Group's Vaxxinity, Inc. Class A Common Stock position peaked at $6.01M in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Vanguard Group's 13F filing for Q2 2024, filed 13 Aug 2024.